System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Ilyes Sakji is an expert in Pharmacy at Centre Oscar Lambret (France). Ilyes Sakji has authored 19 publications, the most recent in 2025. SLR score: 42 (community average: 125). How the SLR is computed.

LeadR Profile

Ilyes Sakji Centre Oscar Lambret France
42 ScienceLeadR Reputation 42

Unlock

Register Login
Network Map

Pharmacy

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2025
Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 19

Citations

Citations: 32 1st author: 0 Last author: 0 Unique author: 0

Main journals

J Oncol Pharm Pract 4
J Clin Oncol 3
Ann Oncol 2
NUTR CLIN METAB 2
Pharmaceutical technology in hospital pharmacy 2

Best Journals

Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Transportation of protein drugs at hospital: Comparison of mechanical stress occurring during pneumatic transportation and hand-carried transport.
PMID 40049322 — pharmaceutical preparations, stress, physiological, pharmacy, transportation		J Pharm Sci20250
Securing the oral and enteral oncopediatric chemotherapy process in pediatric oncology: Introduction of the ENFit™ standard in a controlled-atmosphere area and implementation of a dispensing service of medications to outpatients circuit with advice on proper use.
PMID 38613327 — patient care, medical oncology, syringes, pediatrics, pharmacy, drug therapy, caregivers, atmosphere, outpatients, chemotherapy		J Oncol Pharm Pract20240
5PSQ-123 Simulation of a discharge control: an effective tool for qualifying staff
OpenAlex W4393005315		Section 5: Patient safety and quality assurance20240
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study).
PMID 37438439 — ranitidine, injections, histamine, incidence, paclitaxel, hypersensitivity, premedication, drug therapy, pharmacology		Eur J Clin Pharmacol20233
5PSQ-014 Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel – towards crisis management and a premedication reconsideration in France (PACLIREACT Study)
OpenAlex W4360614898 — injections, histamine, incidence, paclitaxel, hypersensitivity, adrenal cortex hormones, premedication		Section 5: Patient safety and quality assurance20230

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS